Patients who are being treated with metformin for type 2 diabetes might live longer than other people with the condition who aren’t taking the drug, according to researchers at Cardiff University.
Diabetic autonomic neuropathy, a common side effect of diabetes that is linked to a wide range of complications including digestive issues, erectile dysfunction, paralysis of the bladder and intestinal damage, is not only difficult to treat, it’s also difficult to diagnose.
Invokana, a member of the new class of drugs known as sodium glucose co-transporter 2 (SGLT2) inhibitors, was approved in the USA as a single agent in March 2013.
Bioengineers from ETH Zurich’s Department of Biosystems Science and Engineering in Basel have created a prototype implantable molecular device which regulates the blood pH levels through a closed loop pH sensing and insulin production mechanism.
We hear all the hype when new diabetes research is announced: Hey, we’re so excited and think it could be the greatest next big thing. That’s the hope, at least. But what happens if and when that research doesn’t bear any fruit? When the money invested doesn’t produce any potential new therapy or actual product?
Americans are accustomed to being nagged about salt. We’re told we consume too much — particularly from processed foods. And that all this salt can increase the risk of high blood pressure, heart attacks and strokes.
As part of the study, conducted at the Diabetes Center of the General Hospital of Nikaea in Athens, Greece, researchers served desserts after meals to 70 study participants with type 2 diabetes, and found that those containing sucralose and soluble fiber did not elevate after-meal levels of glucose, insulin or C-peptide, an amino acid associated […]
As you may know, our correspondent Wil Dubois was on the ground in Orlando, FL, covering the big annual American Association of Diabetes Educators (AADE) meeting for us last week. Check out his first Newsflash on Asante and Insulet stuff from last Friday. And now, we bring you his full report of product news from […]
Individuals who experience high levels of workplace stress are about 45 percent more likely to develop type 2 diabetes than those who have less taxing jobs, according to research published in the journal Psychosomatic Medicine.
Now, a study published in the journal Diabetologia finds that interval training may help the millions of people with Type 2 diabetes and prediabetes who are trying to control their blood sugar.
In Part 1 of our interview (published last Thursday), Derek told us about his personal connection to diabetes and how he views the JDRF overall as an organization. Today, he delves more deeply into just where he thinks the nonprofit org is going and what he thinks it takes to move forward.
The objective of the study, published in leading diabetes journal Diabetes, Obesity and Metabolism, was to compare all-cause mortality in diabetic patients treated with either sulphonylurea or metformin with matched individuals without diabetes including age, gender, same general practice, smoking status and clinical status criteria.
For people with type 2 diabetes, eating pistachios could help reduce the body’s stress response – which may help lower blood pressure and decrease strain on the cardiovascular system.
Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
A group of scientists headed by Dr. Susanne Neschen and Prof. Dr. Martin Hrabě de Angelis from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and drug manufacturer Sanofi Aventis, have discovered how metformin and SGLT2 inhibitors can reinforce each other when used together. Read more
After a decade-long run, Novo Nordisk’s FlexPen is being retired. Yes, one of the most popular insulin pens for people with diabetes is on the way out after more than 1 billion have been sold through the years. And here comes Novo’s new next-gen FlexTouch.
The drug – a rosiglitazone-based medicine that controls blood glucose by increased the body’s sensitivity to insulin, so cells and muscles are able to use more for energy, reducing levels in the blood – was off the market in Europe and restricted in the United States for several years due to studies showing the drug […]
Many people believe that insulin causes the complications of diabetes. Here is some information to dispel some of these myths about insulin therapy.
For obese adults with type 2 diabetes mellitus (T2DM), a very low carbohydrate diet is associated with greater improvements in glycemic control and cardiovascular risk markers than an energy-matched high unrefined carbohydrate diet, according to a study published online July 28 in Diabetes Care.
Access to continuous glucose montitors (CGMs) shouldn’t be a battle in 2014, but for those people with diabetes covered by Medicare, that’s sadly the case. Now there’s a movement afoot to do something about that.